Carregant...
Anti-PD-1-Induced Hidradenitis Suppurativa
Mucocutaneous adverse events are commonly observed under immune checkpoint inhibitors (ICIs) therapy. Here, we report the case of a 43-year-old male patient with a stage IIIC melanoma disease who developed hidradenitis suppurativa (HS) three months after the beginning of an anti-PD-1 (nivolumab) adj...
Guardat en:
| Publicat a: | Dermatopathology (Basel) |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8008319/ https://ncbi.nlm.nih.gov/pubmed/33668724 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/dermatopathology8010007 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|